Mu et al. [47] conducted a study that suggested that insulin resistance serves a central role in the pathogenesis of EC, and as insulin sensitizer, metformin improves the utilization of insulin by body tissues to reduce insulin resistance. The gene discussed is INS; the disease is Insulin resistance.